Market Overview:
The global non-small cell lung cancer treatment market is estimated to be valued at US$ 24,910.7 million in 2022 and is expected to exhibit a CAGR of 9.4% over the forecast period 2022-2030, as highlighted in a new report published by Coherent Market Insights. Non-small cell lung cancer (NSCLC) is a type of lung cancer that affects the tissues of the lung and is the most common form of lung cancer. The market for non-small cell lung ... Read more
